BioSpace News Archive

Verve Therapeutics to Present at the 39 th Annual J.P. Morgan Healthcare Conference

Jnana Therapeutics , a biotechnology company targeting the solute carrier (SLC) family of metabolite transporters to treat underserved diseases, today announced the appointment of two experienced scientific and clinical leaders to the company’s boards. Annie C. Chen, MD, MPH, Chief Medical Officer of Nimbus Therape

UroGen Pharma to Present at the Virtual 39 th Annual J.P. Morgan Healthcare Conference

Pamela Holland, Ph.D., Joins as Senior Vice President, Research Remy Durand, Ph.D., Promoted to Chief Business Officer

Arcturus Therapeutics Holdings Inc. announced that the Company will participate in a panel discussion taking place at the 13th Annual Biotech Showcase™ Investor Conference:

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced it has been awarded additional non-dilutive funding totaling approximately $4 million from the Walloon Region and Namur Invest, Belgium . To date, Agencies from the Walloon Region have awarded Volition an aggregate of approximately $13 million in non-dilutive

Our new PeDAL fee-for-service offering for Pharmaceutical companies will significantly improve the chances of translating discoveries into the clinic

Transformative Acquisition Deepens Pipeline with In-Process Phase 2/3 Clinical Study of Proprietary Oral Formulation of Niclosamide for the Treatment of COVID-19 Development Timeline Supports Multiple Value Drivers Over Next 12-18 Months

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, “Single position circumferential fusion improves operative efficiency, reduces complications and length of stay compared with traditional circumferential fusion,”

Invetx, a pioneer in protein-based therapeutics for animal health, announced that Dr. Joachim Hasenmaier has joined the company’s board of directors.